Special Advisory Bulletin: Average Manufacturer Price and Average Sales Price Reporting Requirements
Guidance that notifies drug manufacturers of the OIG enforcement initiative concerning the timely submission of data necessary to the effective operation of the Medicaid Drug Rebate Program, the 340B Drug Pricing Program, the Federal Upper Limit Program, and the Medicare Part B outpatient prescription drug benefit.
Issued by: Office of Inspector General (OIG)
Issue Date: September 28, 2010
DISCLAIMER: The contents of this database lack the force and effect of law, except as authorized by law (including Medicare Advantage Rate Announcements and Advance Notices) or as specifically incorporated into a contract. The Department may not cite, use, or rely on any guidance that is not posted on the guidance repository, except to establish historical facts.